<DOC>
	<DOCNO>NCT00253305</DOCNO>
	<brief_summary>The purpose study compare , control fashion , response two anti-fungal agent , naftifine terbinafine , vehicle novel topical gel formulation treatment subject distal subungual tinea unguium toenail ( onychomycosis ) . The formulation use vehicle active agent show early study facilitate penetration active agent fungally-infected nail . This study examine dose-response agent difference term efficacy safety . Once subject qualify study , he/she randomly assign one five study group , dispense appropriate study medication instruct apply one drop great toe designate study .</brief_summary>
	<brief_title>Topical Gel Anti-Fungal Agent Tinea Unguium</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Naftifine</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>clinical diagnosis distal subungual tinuea unguium one great toenail . 20 65 % infected area target nail 2 mm clear nail proximally target nail positive dermatophyte culture positive KOH test able sign inform consent understand requirement study female must postmenopausal agree use approve contraceptive throughout study patient nails infected organism dermatophytes patient proximal subungual tinea unguium patient spikes disease extend nail matrix patient 5 infected nail patient confound problems/ abnormality target nail patient screen lab value 20 % normal patient know hypersensitivity test material component patient require systemic medication may interfere study patient poor history compliance study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>tinea unguium</keyword>
	<keyword>onychomycosis</keyword>
</DOC>